Brivissa 25 Tablet
Marketer
Arinna Lifescience Pvt Ltd
Salt Composition
Brivaracetam (25mg)
Overview Brivissa 25 Tablet
Epileptic seizures are managed with the anticonvulsant medication, Brivissa 25mg tablets. This medication can be a standalone treatment or used in conjunction with other therapies. Consistent use is crucial for ongoing seizure prevention. Brivissa 25mg tablets work by reducing abnormal brain electrical activity. Administer this medication regularly, with or without food, but maintain a consistent daily schedule for optimal effectiveness. Dosage and frequency are determined by your physician to achieve optimal seizure control and may be adjusted incrementally. Long-term use is typically recommended; continue taking it as directed, even if feeling well. Discontinuing or missing doses can exacerbate seizures. Never stop taking Brivissa 25mg tablets without your doctor's instruction, as abrupt cessation can worsen seizures. Common side effects include dizziness, headache, nausea, vomiting, and potential mood alterations such as aggression, irritability, or agitation. These are often more pronounced initially and tend to subside with continued use. While many side effects are minor, some can be severe. Suicidal ideation has been reported in a small percentage of patients. Report any worsening mood changes to your doctor immediately. Prior to commencing treatment, inform your physician of any liver or kidney issues, history of depression or suicidal thoughts, and pregnancy or pregnancy plans. Breastfeeding mothers should also consult their doctor before using Brivissa 25mg tablets.
Uses of Brivissa 25 Tablet
Convulsive disorders
Major Benefits of Brivissa 25 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Brivissa 25 Tablet whole; avoid chewing, crushing, or breaking it. While consumption with or without food is acceptable, consistent timing is recommended.
Common Side effects of Brivissa 25 Tablet:
- Behavioral changes
- Agitation
- Aggressive behavior
- Dizziness
- Sedation
- Drowsiness
- Neuropsychiatric symptoms
How to use Brivissa 25 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Brivissa 25 Tablet whole; avoid crushing, chewing, or breaking it. This medication can be taken with or without food, however, consistency in timing is recommended.
How Brivissa 25 Tablet works:
Brivissa 25mg tablets are used to control seizures. The medication acts by binding to SV2A receptors located on neuronal membranes, thereby reducing excessive neuronal firing and inhibiting the propagation of seizure-inducing electrical impulses within the brain.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Brivissa 25 Tablet is not recommended.
PregnancyCONSULT YOUR DOCTOR
Using Brivissa 25 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Brivissa 25 Tablet use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Taking Brivissa 25 Tablet may cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
Brivissa 25 Tablet is considered safe for patients with kidney impairment; dosage modification is unnecessary. However, its use is not advised in cases of end-stage renal disease, given the absence of supporting clinical trial evidence.
LiverCAUTION
Patients with liver impairment should use Brivissa 25mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Brivissa 25 Tablet :
NA
Facts to Know About Brivissa 25 Tablet
| Label | Value |
|---|---|
| Chemical Type | Levetiracetam Analog |
| Developing Good Habits | No. |
| Treatment Category | Neuroscience Central Nervous System |
| Actions | AED: A protein ligand within synaptic vesicle 2 |


